Abstract
ABSTRACT Chronic kidney disease (CKD) is a global concern and is a serious health issue that is closely associated with cardiovascular disease (CVD). Accordingly, there is a rising clinical demand for promoting the importance of the screening and diagnosis of CVD in CKD patients. The purpose of this research was to assess the effectiveness of blood microRNA-146a and vitamin D levels in CKD detection and cardiovascular complications prediction. When CKD participants, either complicated or not, were compared to the control group, plasma rates of Vascular adhesion molecule-1 (VCAM-1) and microRNA-146a were greater, while serum vitamin D values were markedly smaller. Hence, although blood miR-RNA146a quantities can be used as a reliable and particular CKD biomarker, they cannot be used to identify CVD in CKD patients since its level was not significantly different in CKD and CKD+CVD patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
